M&A Deal Summary

Italfarmaco Acquires Lacer

On July 24, 2022, Italfarmaco acquired life science company Lacer

Acquisition Highlights
  • This is Italfarmaco’s 1st transaction in the Life Science sector.
  • This is Italfarmaco’s 1st transaction in Spain.

M&A Deal Summary

Date 2022-07-24
Target Lacer
Sector Life Science
Buyer(s) Italfarmaco
Deal Type Add-on Acquisition

Target

Lacer

Barcelona, Spain
Lacer is a pharmaceutical company that operates through two segments: personal care and prescription drugs. The company specializes in segments such as oral hygiene, the treatment of varicose veins, and hair loss. Lacer was formed in 1949 and is based in Barcelona, Spain.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Italfarmaco

Milan, Spain

Category Company
Founded 1938
Sector Life Science
DESCRIPTION

Italfarmaco is a multinational company that operates in Italy and abroad in the pharmaceutical and chemical-pharmaceutical sector, with products with a high therapeutic content that mainly fall into the cardiovascular, immuno-oncological, and gynecological areas. The company has modern and sophisticated industrial plants where it produces medicinal specialties in pre-filled syringes, sterile preparations for injection, oral, solid, and liquid products. Italfarmaco was formed in 1938 and is based in Milan, Spain.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Spain M&A 1 of 1
Year: 2022 M&A 1 of 1